| Bioactivity | 1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine |
| CAS | 136020-18-3 |
| Formula | C10H15N3O5 |
| Molar Mass | 257.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine
CAS: 136020-18-3 F: C10H15N3O5 W: 257.24
1-(2,3-Dideoxy-β-D-erythro-hexo pyranosyl)cytosine is a purine nucleoside analog. Purine nucleoside analogs have broad
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.